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 We consider a complex industrial bioseparation that experiences process variability.
 A mechanistic modeling approach is used to determine how to assure product quality.
 Probabilistic design spaces are generated from stochastic simulations.
 The impact of process parameter mean and variance on quality assurance is determined.
 Signiﬁcant increases in robustness can be gained from adapting operating conditions.
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a b s t r a c t
A model based approach has been developed and used to identify robust operating conditions for an
industrial hydrophobic interaction chromatography where resin lot variability, combined with feed
stream variability, was resulting in serious performance issues during the puriﬁcation of a multi
component therapeutic protein from crude feed material. An equilibrium dispersive model was
formulated which successfully predicted the key product critical quality attribute during validation
studies. The model was then used to identify operating parameter ranges that assured product quality
despite the process variability. Probabilistic design spaces were generated using stochastic simulations
that showed the probability that each resin lot would meet product quality speciﬁcations, over a range of
possible operating conditions, accounting for the historical variability experienced in the load material
composition and concentration. No operating condition was found with normal process variability
where quality assurance remained 40.95 for resins that gave the highest and lowest product recoveries
during process development. The lowest risk of batch failure found was 16%, and operating conditions
were not robust. We then extended the stochastic methodology used to generate probabilistic design
spaces, to identify the level of control required on the load material composition and concentration to
bring process robustness to an acceptable level, which is not possible using DOE experimental methods
due to the impractical amount of resources that would be required. Although reducing inlet variability
resulted in an increase in the assurance of product quality, the results indicated that changing operating
conditions according to which resin lot is in use is the favorable option.
& 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
1. Introduction
There is an increasing desire within the pharmaceutical indus-
try to develop and operate processes following a Quality by Design
(QbD) approach, where quality is built into the product and the
process based on a high level of product knowledge and process
understanding. In this approach, critical quality attributes (CQA) of
pharmaceutical products are deﬁned that assure desired clinical
performance, and then a manufacturing process is designed to
consistently meet these product attributes, thus assuring product
quality (ICH, 2008a). Process characterization is conducted to
identify the impact of process parameters on the products CQA's
(Jiang et al., 2010), which is then used to deﬁne a process design
space. A design space is deﬁned by the International Conference
on Harmonisation (ICH) guidance document as “the multidimen-
sional combination and interaction of input variables and process
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parameters that have been demonstrated to provide an assurance of
product quality” (ICH, 2008a). Acceptable ranges for process para-
meters and input variables are documented in the regulatory
ﬁling, and working within these ranges is not deemed to be a
change from normal operating conditions. The expected beneﬁt of
the QbD approach is an increase in the assurance of product
quality, and in turn, the FDA will allow manufacturers greater
ﬂexibility to operate with lower regulatory burden, enabling
continuous process improvement, as well as greater robustness
(ICH, 2005, 2008a, 2008b).
The current approach to process characterization to identify the
design space, involves ﬁrst performing a qualitative risk analysis to
identify parameters for process characterization, e.g. failure mode
effects analysis or fault tree analysis (ICH, 2005, Harms et al., 2008).
Based on the outcome of this assessment, design of experiment
(DOE) studies are conducted to generate data amenable for use in
understanding and deﬁning the acceptable parameter and input
variable ranges that make up the design space (Rathore and
Winkle, 2009). An important aspect of this characterization effort is
concerned with validating that the deﬁned design space can cope
with the process variability experienced during normal operation
(Rathore, 2009). This variability is a key driver in the current
approach to the design and development of industrial biopharma-
ceutical separations, which promotes a focus on identifying the most
robust operating conditions, rather than optimizing for particular
scenarios. Process robustness is typically validated via an extensive
experimental effort directed by factorial design of experiments to test
that the product quality remains within the deﬁned product attri-
butes during normal operation, and this is approach is clearly sub-
optimal, time consuming and costly.
We consider an industrial chromatographic separation where
resin lot variability, combined with a variable feed stream, had
resulted in serious performance issues during the puriﬁcation of a
therapeutic protein from crude feed material. The resin lot
variability occurred on a hydrophobic interaction chromatography
(HIC) that provides impurity clearance whilst producing a complex
product composed of six closely related variants of a dimer protein
therapeutic (30 kDa), with their monomer subunits in a speciﬁc
ratio. Impurity removal is well understood; however, achieving the
correct monomer subunit ratio poses a signiﬁcant puriﬁcation
challenge. The desired ratio of monomer subunits must be met by
this unit operation, and is a deﬁned CQA of the ﬁnal product. An
extended range of resin lots were obtained from the supplier for
testing within normal process operating ranges during process
development conducted prior to this study. All resin lots were
within the manufacturers speciﬁcations for ligand density and
chloride capacity. Despite this, many failed to meet product quality
speciﬁcations during testing and would have incurred signiﬁcant
losses if used for the large scale manufacture of the product. No
link between resin lot speciﬁcations and successfully meeting
process objectives was found.
Mechanistic models are ideally suited to assist in the development
of robust puriﬁcation processes, as they can efﬁciently investigate
design alternatives with minimal experimentation, whilst deriving
fundamental knowledge and process understanding in line with FDA
recommendations. They have been successfully applied to many
chromatographic separations (Melter et al., 2008; McCue et al.,
2008; Nagrath et al., 2011), with useful examples on optimization
(Degerman et al., 2007; Ng et al., 2012), scale up (Mollerup et al.,
2007; Gerontas et al., 2010), and process development (Osberghaus
et al., 2012), although the practical challenges of industrial separa-
tions mean their application to true industrial systems with crude
feed mixtures is not yet routine, and can involve a lengthy experi-
mental effort to calibrate parameters and validate predictions (e.g.
Gétaz et al., 2013a,2013b; Nfor et al., 2013). Model based approaches
to sensitivity and robustness analysis are of particular relevance to
industrial separations as they can ensure puriﬁcation processes are
robust, which is a key requirement for bioseparations (Jakobsson
et al., 2005; Degerman et al., 2009; Westerberg et al., 2012; Borg et
al., 2013). These approaches enable the impact of disturbances in
process parameters on meeting CQA's to be quantiﬁed quickly and
efﬁciently, thereby indicating the risk of batch failure, with minimal
time, material and analytical constraints. The additional knowledge
and process understanding gained by their use may offset the extra
investment of time and material for model development and valida-
tion, and fulﬁls regulatory guidance regarding the implementation of
Quality by Design and the proposed greater use of mechanistic
models (ICH, 2008a).
In this paper, a model based approach is developed and used to
identify robust operating conditions for the HIC that ensure the
desired product quality is met, despite the resin lot and inherent
bioprocess variability. The HIC had predeﬁned mobile phase
conditions, ﬂow rate and column dimensions that were ﬁxed prior
to this work, leaving the mass challenge and wash length as the
only manipulated variables available for adjustment. An equili-
brium dispersive model with competitive Langmuir adsorption is
developed for the two most extreme resin lots which gave the
highest (designated high binding resin) and lowest (designated
low binding resin) protein recoveries at normal operating condi-
tions. Micro well batch adsorption and scale down column
experiments are used for model calibration, and the model is
validated against multiple scale down column experiments over
an extended range of inlet variables and process parameters.
The validated mechanistic model is then combined with stochastic
simulation to generate probabilistic process design spaces for each
resin lot. The results show the probability of meeting product quality
speciﬁcations (i.e. product CQA's), over a range of possible operating
conditions, whilst accounting for process uncertainty based on the
historical variability experienced in the load material composition and
concentration. The data is used to determine operating conditions that
are eligible for all resin lots, by assuming that the operating conditions
that assure product quality for the extreme high and low resin lots are
suitable for all other resin lots. We then demonstrated how the
stochastic methodology was used to generate probabilistic design
spaces can be extended, when current uncertainty results in an
unsatisfactory design space, in order to identify the level of control
required on uncertain variables to bring process robustness to an
acceptable level. The control required on the load material composi-
tion and concentration is determined. The presented approach can be
used with any validated mechanistic model with parameters that are
variable or uncertain, and enables the rapid exploration of the tradeoff
between control of process parameters and the robustness of the
design space, which is not possible using DOE experimental methods
due to the impractical amount of resources that would be required.
FDA guidance encourages the application of mechanistic models
to improve process understanding, based on fundamental knowledge
of the underlying causes linking process parameters to product
CQA's. The methodology demonstrates how useful mechanistic
models can be for this task, for as well as determining the functional
relationship between process parameter values and the resulting
value of the CQA, the use of models can quickly and efﬁciently
determine the relationship between process parameter and CQA
variances, a key aspect of providing assurance of product quality.
2. Experimental materials and methods
2.1. Materials
2.1.1. Therapeutic protein and feed material
The product of interest is a disulﬁde linked dimer protein molecule
(MW¼30 kDa), comprised of twomonomer subunits. Three variations
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of the monomer subunit exist due to slight variations in the amino
acid sequence, here denoted A, A and B. This results in six possible
isoforms of the dimer (AA; AA; AA; AB; AB and BBÞ as illustrated in
Fig. 1. The corresponding analytical chromatogram is shown in Fig. 2A.
Each form is an active component of the ﬁnal product which must
contain a speciﬁc ratio of the monomer subunits, ðAþAÞ : B, i.e. not
just one product form at a given total amount is required, but six
closely related dimer variants, with a given ratio of their monomer
subunits. Speciﬁcally, subunit B must account for between 25 and 45%
of all monomer subunits in the product, i.e. 0.25oBo0.45. In addition
to the product, the HIC feed material contains several product related
impurities accounting for up to 25% by mass of the feed material,
including the individual monomer subunits (A, A and B), incorrectly
formed product species (MW¼42, 60, 80 and 100 kDa), and host cell
related contaminants consisting of mainly host cell protein (HCP) and
DNA. The corresponding analytical chromatogram is shown in Fig. 2B.
2.1.2. Chromatography resin
Multiple (420) Butyl Sepharose 4B fast ﬂow hydrophobic
interaction resin lots were obtained from GE Healthcare (Uppsala,
Sweden). The two most extreme resin lots were selected for this
work based on protein recovery in process development experi-
ments (not shown), and are designated high and low binding
resin, e.g. the high binding resin gave high protein recoveries and
the low binding resin gave low protein recoveries. Both resins
were with the manufacturers' speciﬁcations.
2.1.3. Equipment
All preparative scale laboratory experiments were carried out
using an ÄKTA FPLC chromatography system from GE Healthcare
(Uppsala, Sweden). Laboratory columns were 1.1–3.2 cm in dia-
meter and 7.4 cm in bed height. A GE Healthcare Mono S column
(5.0 mm50 mm) high performance liquid chromatography
(HPLC) column was used for analytics.
2.2. Experimental methods
2.2.1. Hydrophobic interaction chromatography
During all runs, the columns were ﬁrst equilibrated with
50 mM Tris, 1.0 M NaC1, 0.50 M Arg-HC1, pH 7 equilibration buffer.
The elution peak from a preceding pseudo afﬁnity capture chro-
matography was brought to the correct NaCl concentration and
applied to the column at 4.2 CV/h, followed by a wash step using
the equilibration buffer. Elution buffer consisting of 20% Propylene
Glycol, 50 mM Tris, 0.50 M Arg-HCl, pH 7 was then applied and the
product peak collected. The pooling policy was ﬁxed for all runs.
Any remaining bound protein was removed in a strip step using
0.1 M Sodium Acetate, pH 4 sanitization buffer, and the column
was stored in storage buffer when not in use. The efﬁcacy of the
elution stage is well understood, and was experimentally validated
during process development. Negligible amounts of protein
remain in the column after the elution stage and all mass balances
were satisfactory during experimental runs. All experiments were
conducted between 4 and 8 1C.
2.2.2. Cation exchange HPLC assay
A cation Exchange (CEX) HPLC assay was used to determine the
relative percentages of the six dimer isoforms of the product in
samples, and utilized a Mono S column and a gradient of sodium
acetate, acetonitrile and sodium chloride at pH 5. The relative
percentage area of the six peaks in the chromatogram indicated
the percentage of each isoform in the sample (Fig. 2. Top).
2.2.3. Phenyl reverse phase HPLC assay
A Phenyl Reversed Phase (RP) HPLC assay was used to determine
the relative amount of product and product related impurities in
samples, and utilized a TSK-Phenyl reversed phase column and a
water/acetonitrile/triﬂuoroacetic acid gradient system (Fig. 2.
Bottom).
2.2.4. Batch adsorption experiments
Batch adsorption experiments were required to generate data
for calibrating the equilibrium adsorption isotherm parameters.
Puriﬁed protein solutions for batch adsorption experiments were
generated from bulk feed material by purifying and isolating
product forms from impurities over multiple runs of the HIC.
Batch binding studies based on the work of Coffman et al. (2008)
were conducted in a 96-well ﬁlter plate and were repeated in
triplicate. The ﬁlter plates used throughout the experiments were
Fig. 1. The product is a disulﬁde linked dimer protein therapeutic (MWE30 kDa),
comprised of two monomer subunits. Three variations of the monomer subunit
exist due to slight variations in the amino acid sequence, here denoted A, A and B.
This results in six possible forms of the dimer, all of which are active components of
the ﬁnal product and thus must be present in the elution peak in a speciﬁc
distribution.
Fig. 2. Analytical chromatogram of Top. the product and Bottom. the feed material.
(Axis values deliberately removed for conﬁdentiality purposes).
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round-well 800 μl plates with 0.45 mm pore-size polypropylene
membrane. 25 μl of resin was taken from a bulk reservoir and
dispensed by the robotic liquid handler into the individual wells as
25% (v/v) slurry in the appropriate equilibration buffer. The plate
was then centrifuged to evacuate excess liquid and leave damp
resin. Subsequently, other solutions composed of pure product,
having various total protein concentrations (0.5–1 mg/ml) and
isoform distributions (each component was varied between 20
and 60%) were added into wells containing the resin. The initial
concentration and component distribution for each ﬁlter plate
well were fashioned by mixing together protein from bulk solu-
tions of known component distributions and concentrations, with
the appropriate amount of equilibration buffer from a bulk solu-
tion in order that the total volume of liquid dispensed into each
well was 275 mL (Vtot). The resin and solutions were then agitated
on a platform shaker for 120 min. Separate batch uptake studies
indicated that equilibrium was reached in less than 30 min (not
shown), and therefore that this incubation time was suitable. Foil
adhesive tape was used on the underside of the ﬁlter-plate to
prevent liquid loss during shaking. After incubation, a centrifuge
evacuated the supernatant into a UV-transparent 96 well micro
plate which was stacked beneath the ﬁlter plate for analysis. The
supernatant was then analyzed by a 96-well UV spectrophot-
ometer (SpectraMax 250, Molecular Devices, Sunnyvale, CA) to
determine the concentration of protein in the supernatant, Cmi .
CEX HPLC was used to determine the percentage of each compo-
nent in the supernatant, Pmi . The concentration of the protein in
the mobile phase is calculated
Cmi ¼
CequilP
m
i
100
ð1Þ
where Cmi is the concentration of component i in the mobile phase
(mg/ml), Cequil is the measured concentration in the supernatant of
the micro well, determined by UV spectroscopy, and Pmi is the
percentage of component i in the mobile phase as determined by
CEX HPLC. An elution cycle was then conducted following the
same methodology as the load cycle, where 275 mL of elution
buffer was added to each well, the plate agitated on a platform
shaker for 120 min and the supernatant subsequently collected as
described previously and analyzed using the spectrophotometer
and CEX HPLC. The total amount of protein added to each micro
well was then determined by Eq. (2)
Mt ¼
Celution
Velution
þ Cequil
Vequil
ð2Þ
whereMt is the total amount of protein added to the microwell (mg),
Celution is the concentration of the elution supernatant (mg/ml),
Velution is the volume of the elution supernatant (ml), Cequil is the
concentration of the equil supernatant (mg/ml), and Vequil is the
volume of the equil supernatant (ml). The amount of protein
adsorbed per unit volume settled resin, qi (mg/ml), is calculated
using Eq. 3:
qi ¼
MtP
load
i
100 Cmi Vequil
 
Vresin
ð3Þ
where Ploadi is the percentage of component i in the load material and
Vresin is the settled volume of resin in the microwell (25 μl).
2.2.5. Pulse injection experiments
Pulse injection experiments were required to determine the
total column porosity, ϵT . Pulses of NaCl were injected onto the
column system and the retention time measured, accounting for
dead time in the system. All experiments were performed in
triplicate. The total column porosity, ϵT , was calculated by the
following equation:
ϵT ¼
t0F
VC
ð4Þ
where t0 is the retention time of the unretained molecule (s), F is the
mobile phase ﬂowrate (ml/s), and VC is the column volume (ml).
3. Mathematical methods
3.1. Process assumptions
The similar amino acid sequence of two of the monomer
subunits (A and A) results in similar separation properties of the
product isoforms AA;AA; AA and of the product isoforms AB; AB .
In order to simplify the modeling problem, the six product
isotherms were reduced in the model to three components:
AA; AB; and BB. We assumed that all product isoforms that remain
bound to the column after the load and wash steps are subse-
quently collected in the elution step, thus only the load and wash
stages of the separation are simulated, and that the product
related impurities and HCP's in the feed stream had a negligible
impact on the separation of the product of interest, as the
impurities are observed to ﬂow through during the load phase of
the chromatographic cycle. Both of these assumptions were
conﬁrmed experimentally (Close et al., 2014).
3.2. Equilibrium dispersive model
An equilibrium dispersive model was chosen to simulate the
HIC (Guiochon et al., 1994; Kaczmarski et al., 2001) as it is faster to
solve than the general rate model, which was important for
reducing total stochastic simulation time, and because fewer
model parameters need to be determined, whilst still predicting
the product CQA sufﬁciently well (as will be shown in Section 4).
The model assumes that the mass transfer kinetics between the
mobile phase moving through the column bed and the particles is
inﬁnitely fast. Thus the concentration of component i in the
mobile phase is equal to the average concentration of component
i in the intra-particular mobile phase, and the axial dispersion
coefﬁcient is replaced with an apparent axial dispersion coefﬁ-
cient, DA (cm
2/s), which includes the contribution from the
mass transfer kinetics. The assumption was reasonable for this
system due to the low ﬂow rates (4.2 CV/h). The model has the
following additional assumptions: (i) The column is unidimen-
sional (radially homogeneous), (ii) the chromatographic separa-
tion is isothermal and adiabatic, (iii) the compressibility of the
mobile phase is negligible and thus the velocity proﬁle is ﬂat, and
(iv) the mass transfer parameters are independent of component
concentration.
Assuming that the column is radially homogeneous, the differ-
ential mass balance in the bulk mobile phase is described by
(Guiochon et al., 1994)
∂Cmi
∂t
þð1ϵT Þ
ϵT
∂Cspi
∂t
þu∂C
m
i
∂z
¼DA
∂2Cmi
∂z2
8 i¼ 1; 2; …; NC zAð0; LÞ
ð5Þ
where Cmi is the concentration of component i in the mobile phase
(mg/ml), t is the time (s), ϵT is the total column porosity, C
sp
i is the
concentration of component i in the stationary phase (mg/ml), u is
the interstitial velocity (cm/s), z is the axial coordinate, DA is the
apparent axial dispersion coefﬁcient (cm2/s), NC is the number of
components in the system, and L is the column length (cm).
∂Cmi =∂t is the rate per unit volume of accumulation of component i
in the mobile phase, ðð1ϵT Þ=ϵT Þð∂Cspi =∂tÞ is the rate per unit
volume of accumulation of component i in the stationary phase,
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uð∂Cmi =∂zÞ is the rate per unit volume of mass transfer by convec-
tion down the column, and DAð∂2Cmi =∂z2Þ is the rate per unit
volume of mass transfer by dispersion and particle mass transfer
kinetics lumped into one term.
The boundary conditions for Eq. (5) are the following:
At the inlet of the column, z¼0, the mobile phase concentra-
tion, Cmi , depends on convection and dispersion:
uCmi –DA
∂Cmi
∂z
 
z ¼ 0
¼ uCmi;0 i¼ 1; 2; …; NC ð6Þ
where Cmi;0 is the inlet concentration.
At the outlet of the column, z¼L, only convective transport is
considered:
∂Cmi
∂z

z ¼ L
¼ 0 8 i¼ 1; 2; …; NC ð7Þ
An initial condition is also required to solve Eq. (5), and this states
that the rate per unit volume of accumulation in the mobile phase
of component i within the column at t¼0 is zero:
∂Cmi
∂t
¼ 0 0ozoL 8 i¼ 1; 2; …; NC ð8Þ
Protein adsorption onto the stationary phase was modeled using a
competitive Langmuir adsorption isotherm (Seidel-Morgenstern,
2004).
qi ¼
qska;iC
m
i
1þ∑ka;iCmi
8 i¼ 1; 2; …; NC zAð0; LÞ ð9Þ
where qs is the resin saturation capacity, and ka;i is the equilibrium
constant of component i, and qi represents the amount of protein
adsorbed per unit volume of settled resin. When the adsorption
isotherm (Eq. 9) is linked with the differential mass balance in the
bulk mobile phase (Eq. 5), the amount of protein adsorbed per unit
volume of settled resin, qi, is converted to the amount of protein
adsorbed per unit volume of stationary phase in the packed bed,
Cspi :
Cspi ¼
CFqi
ð1ϵT Þ
8 i¼ 1; 2; …; NC zAð0; LÞ ð10Þ
Where, dividing qi by ð1ϵT Þ accounts for the phase ratio
(Mollerup, 2008), and multiplying qi by a compression factor, CF ,
deﬁned as the ratio between settled bed volume and packed bed
volume, accounts for bed compression (Gerontas et al., 2010).
The necessary compression had been determined experimentally
during process development in order to prevent the formation of
column headspace under ﬂow conditions. All model equations are
implemented and solved using the dynamic simulation tool
gPROMS™ (Process Systems Enterprise, 2013). Discretization of
the column in the axial coordinate is done using the built-in
orthogonal collocation on ﬁnite element method (OCFEM).
3.3. Parameter estimation
The ‘parameter estimation’ entity in gPROMS™ is based on the
SRQPD sequential quadratic programming code and was used to ﬁt
adsorption isotherm parameters in Eq. (9) (qs; ka;i) and the
apparent axial dispersion coefﬁcient in Eq. (5) (DA). Parameter
estimation was based on the maximum likelihood formulation,
which determines values for the uncertain physical and variance
model parameters that maximize the probability that the
model will predict measured values from development experi-
ments (Process Systems Enterprise, 2013). First the adsorption
isotherm parameters are estimated by ﬁtting the competitive
Langmuir isotherm model to the three component competitive
adsorption data from the micro well batch adsorption experiments
(Section 2.2.4). For estimation of the apparent axial dispersion
coefﬁcient, the full equilibrium dispersive model with competitive
Langmuir adsorption is ﬁtted to experimental product form dis-
tributions in samples taken every CV during the wash of a scale
down column run (Section 2.2.1.).
3.4. Stochastic simulations
The sequence of calculations is illustrated in an example shown in
Fig. 3, which is discussed in detail in the results and discussion section
of this work. For variables of interest, instead of assigning a literal
value, a stochastic value is assigned where the batch to batch
variability is accounted for by specifying the average and standard
deviation. When simulating the chromatography using the model, a
built in function within gPROMS is used that returns a random value
sampled from a normal distribution generated using the speciﬁed
average and standard deviation. Each time a simulation is run, a
different value is picked for the variable of interest. Multiple simula-
tions (45000) were conducted at each unique operating point in
order to determine how variability in the variable of interest affects
the ability of the process to meet critical quality attributes (CQA) of the
outlet stream, as deﬁned by the process objectives. The CQA con-
sidered was the ratio of the monomer subunits, ðAþAÞ : B in the
elution pool. In each individual simulation, the variable of interest is
randomly assigned at the start of the simulation and the resulting CQA
is recorded at the end and used to generate a probability density
function (PDF). By normalizing the PDF by the total number of
simulations, the area under the PDF curve is equal to one, therefore,
the area under the curve where the process objective is met is the
probability that the objective will be met at that operating point. The
probability of meeting the process objective is calculated for all
potential operating points and combined into one graph to generate
a probabilistic design space which shows the probability of meeting
the process objective at each operating point, considering process
variability.
In this work, we considered the variability in the load material
concentration and composition, and neglected the impact of errors in
model predictions, as well as uncertainty in controlled variables such
as ionic strength, bed height etc. Our rational for this is discussed later.
The exact parameter varied in the mechanistic model was the inlet
concentrations of the load material, Cmi;0. Historical averages and
standard deviations from manufacturing data were used to generate
probabilistic design spaces for current process variability (Table 1). In
order to identify the level of control required on uncertain variables to
bring process robustness to an acceptable level when current uncer-
tainty results in an unsatisfactory design space, standard deviations in
model simulations were manually assigned assuming that better
control would result in less variability, and therefore a reduced
standard deviation. Manually changing the load concentration average
is also possible, and may be of interest as feed dilution is trivial, but
this was not considered in this work.
Simulation time for each operating point was approximately
20 minutes using a 3.4 GHz AMD Phenom II X4 965 processor with
8 GB DDR3 RAM. A multi scale model was formulated within
gPROMS and linked with Excel enabling all simulations (i.e.
calculations at all operating points) to be conducted overnight,
with data automatically exported to Microsoft Excel and trans-
formed into probabilistic design spaces.
4. Results and discussion
4.1. Model calibration
Targeted micro well batch adsorption experimentation
(Section 2.2.4.) was utilized to generate data for estimating the
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adsorption isotherm parameters, qs, ka;i. Fig. 4 shows the multi-
component competitive adsorption data from the micro well
experiments for the high and low binding resin lots, at four
different load material product distributions shown on the
graphs in the ratio AA%:AB%:BB%. The product form distribution
in the load material was varied to ensure that the competition
between the closely related product forms was captured in
the isotherm model. Note that although the graphs show the
bound concentration, qi, of the product form as a function of its
mobile phase concentration, Ci, the mobile phase concentration
of the other two product forms are also affecting the bound
concentration.
Fig. 3. Example of the stochastic modeling technique used in this work. (A) Normal distribution of inlet concentration of example product form from historical operating
data. (B) Example of randomly selected inlet concentrations of product form AA during the ﬁrst 1000 stochastic simulations. (C) Percentage B in elution peak over the ﬁrst
1000 simulations. (Mass challenge 2 mg/ml, 5 CV wash length). (D) Probability density function of product CQA (%B) with area highlighted where product quality is met.
Table 1
Historical average and standard deviations of product form inlet concentrations.
Variable name Variable notation Average (mg/ml) Standard deviation
AA inlet concentration Cm1;0 0.108 0.024
AB inlet concentration Cm2;0 0.127 0.023
BB inlet concentration Cm3;0 0.104 0.023
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The estimated isotherm parameter values are shown in Table 2.
The standard deviations of the estimated parameters are approxi-
mately ten percent, indicating there is still some uncertainty in the
parameter values. The coefﬁcient of determination, r2, for the
model ﬁt to experimental data was 0.93 for the high resin and 0.96
for the low resin. This was found to be sufﬁcient for satisfactory
agreement between model predictions and experimental data
given the inherent uncertainties of the batch adsorption experi-
ments (Seidel-Morgenstern, 2004). Interestingly, the estimated
saturation capacity of the Langmuir isotherm, qs, were similar
for both resins; however, the equilibrium constants differed for all
three components. This indicated that the source of the resin lot
variability was associated with protein adsorption-desorption
kinetics and not the maximum saturation capacity. A detailed
investigation into the exact mechanism behind this variability was
beyond the scope of this work, but would be of great interest.
Both resin lots showed signiﬁcant competition between product
forms, with component BB particularly vulnerable to displacement by
the more strongly binding AA and AB forms. In graph 4C, the BB
stationary phase concentrations are signiﬁcantly higher compared to
Graph 4B. This is due to the favorable product distribution in the load
material resulting in fewer competing components, allowing more BB
to bind (graph 4C load material 20% AA:25% AB:55% BB, graph 4B load
material 28% AA:59% AB:13% BB). It was found that the low binding
resin had lower binding capacities than the high binding resin.
This was especially clear for the BB component as shown in Fig. 4C
where the low binding resin BB stationary phase concentration is
approximately half that of the high binding resin.
Pulse injections onto scale down columns (Section 2.2.5) using an
unretained molecule (NaCl) found that both resin lots had the same
total column porosity, (ϵT ¼ 0.970.02), which was in agreement with
the previous literature estimations for this resin (McCue et al., 2007).
The apparent axial dispersion coefﬁcient, DA, was estimated by
ﬁtting the full equilibrium dispersive model to experimental
product form distributions in samples taken every CV during the
wash of a scale down column run. We found that the estimated
apparent axial dispersion coefﬁcients, DA, for high and low binding
resin lots were very similar (high resin¼0.029 cm2/s and low
resin¼0.03 cm2/s), indicating that mass transfer was not respon-
sible for differences between the resin lots.
4.2. Model validation
Multiple scale down column runs were conducted for each resin
lot in order to provide a rigorous test of model predictive capacity,
where the product form distribution was measured across the wash
phase and in the elution peak. An extensive experimental validation
of model predictive capability across the complete design space to
be explored was unfeasible due to industrial time and material
constraints. However, the isoform distribution in the load material,
total load concentration and load challenge were carefully selected
(Table 3) to provide wide ranging coverage of the envisaged design
space, and model predictions were also compared with existing
elution peak product data from scale down experiments which had
been conducted previously by Pﬁzer puriﬁcation process develop-
ment, at load concentrations, load challenges and wash lengths
considerably different from those conducted by the authors of this
work. The ﬂowrate, F , wash length, t, bed compression, and bed
height, L, were kept constant throughout all runs (compression
factor for both resins¼1.25), and a range of column volumes were
used (7, 15 and 60 ml). For both resins, the model was able to
Fig. 4. Multi-component competitive adsorption isotherms for the high and low binding resin lots, at a range of load material product distributions as shown on the graphs in the
order AA%: AB%: BB%. (All experimental points were repeated in triplicate and standard error is shown on the graphs). (A) 53:26:21, (B) 28:39:13, (C) 25:20:55 and (D) 31:37:32.
Table 2
Model parameter values obtained for low and high binding resins based on batch
adsorption and scale down column experiments, ﬁtted using parameter estimation
in gPROMS.
Parameter name Parameter
notation
Low High
AA equilibrium constant ka;1 4.33 6.33
AB equilibrium constant ka;2 1.49 2.30
BB equilibrium constant ka;3 0.52 1.01
Saturation capacity (mg/ml) qs 6.45 6.39
Total column porosity ϵT 0.9 0.89
Apparent axial dispersion coefﬁcient
(cm2/s)
DA 0.0029 0.003
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successfully predict the product form distribution across the wash
and in elution peaks in all scale down model validation column
runs, both from this work, and those conducted separately by
Pﬁzer. Fig. 5 shows examples where model predictions are com-
pared with experiments. Model elution peak composition was
consistently within 75% of experimentally measured values
(values reported in Table 4), which was similar to the accuracy
seen in design of experiment driven statistical response surface
models of this process at Pﬁzer. This is signiﬁcant, as it demon-
strates that despite the complex feed stream and wide range of
conditions tested, a relatively simplistic equilibrium dispersive
model can provide similar accuracy predictions to a DOE type
approach to design space generation, often used in industry.
4.3. Stochastic simulations
The mechanistic models developed for the high and low resin
lots can determine the operating conditions where product quality
speciﬁcations will be met for a known inlet concentration and
composition. However, in practice, for industrial chromatographic
separations the feed material is often uncharacterised prior to
column loading, and will vary from batch to batch depending on
upstream operations. In this work, a model based approach
combining the validated mechanistic model with stochastic simu-
lation is used to account for the inherent variability of inlet
concentration and composition when determining the ability of
a resin lot to meet the process objectives (or conversely the risk of
batch failure).
The methodology is illustrated in an example which shows the
data generated at one potential mass challenge – wash length
combination. The component inlet concentration distributions
were generated from historical data, and are shown in Fig. 3A.
Averages and standard deviations are shown in Table 1. For
illustrative purposes the ﬁrst 1000 randomly generated inlet
concentrations of product form AA is shown in Fig. 3B, and the
corresponding value of the product CQA (i.e. subunit B must
account for between 25 and 45% of all monomer subunits in the
product, i.e. 0.25oBo0.45) is shown in Fig. 3C. It is a straightfor-
ward procedure to generate useful statistical information with this
data regarding CQA variance at each operating point, such as
moments and quartiles, as shown in Fig. 6 for the low binding
resin. The statistical data can be conveniently displayed using a
box and whisker plot. The bottom and top of the box are the ﬁrst
and third quartiles, and the band inside the box is the median. The
end of the lower whisker represents the datum still within
1.5 interquartile range (IQR) of the lower quartile, and the end of
the upper whisker represents the datum still within 1.5 IQR of the
upper quartile. The minimum and maximum of the data is
indicated in the whiskers by a straight line, and the 1% and 99%
quartiles are represented by crosses. Outliers are plotted as dots.
More sophisticated statistical techniques can be employed to
analyze multivariate interactions and CQA dependencies. The
derived data can play a key role in the quality risk assessments
recommended by FDA guidance when developing quality products
(ICH, 2005). The data was transformed into probability density
functions which were used to calculate the probability of meeting
the product CQA as a function of inlet uncertainty, as also shown
in Fig. 6. Probabilistic design spaces were then generated by
plotting the probability of meeting the product CQA (B%) as a
function of available manipulated variables, e.g. mass challenge
and wash length.
Table 3
Model validation runs: product percentage in load, load concentration, and load
challenge.
Run identiﬁer Load Challenge
(mg/ml resin)
Load Concentration
(mg/ml)
AA % AB % BB %
A 1.5 0.26 35 35 30
B 2.2 0.35 40 44 16
C 2.4 0.44 14 38 48
Fig. 5. Experimental and simulated product form distributions during load, wash and in ﬁnal elution peak in model validation runs. Top. High resin. Bottom. Low resin. Left.
Case study A. Right. Case study B. (7 ml CV, 7.4 cm bed height, 4.2 CV/h, load details shown in Table 3).
Table 4
Model validation runs: Experimental vs simulated percentage A and B in
elution peaks.
Resin
identiﬁer
Run
identiﬁer
Exp
% A
Sim
% A
Difference Exp
% B
Sim
% B
Difference
High A 81 79 3 19 21 þ3
B 85 82 3 15 18 þ3
C 71 68 3 29 32 þ3
Low A 90 90 0 10 10 0
B 93 93 0 7 7 0
C 86 81 5 14 19 þ5
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Accounting for uncertainty in controlled variables such as ionic
strength was beyond the scope of this work, but can be integrated
into simulations if desired. In this case, a suitable isotherm with a
parameter that can be assigned uncertainty concerning ionic
strength, such as the steric mass action (SMA) isotherm, would
be required (Brooks and Cramer, 1992). In addition, the impact of
model uncertainty on stochastic predictions can be included,
although this was neglected in this work as the CQA variance
(e.g. 10–42% in the example shown in Fig. 6) was typically much
larger than the largest model error found during model validation
studies (75%). Despite this, the uncertainty in model predictions
cannot be easily neglected and care must be taken to ensure that
robust operating areas identiﬁed by model predictions are tested
experimentally.
Probabilistic design spaces for the low and high resin lots are
shown in Fig. 7. The design space is deﬁned as the multidimen-
sional combination and interaction of input variables and process
parameters that have been demonstrated to provide assurance of
product quality, i.e. that the product CQA's is met. The key
characteristic of probabilistic design spaces is that they provide
quantitative information on the assurance of quality, accounting
for both the mean and the variance of uncertain process para-
meters and variables. No combination of mass challenge and wash
length was found for either resin lot which had a probability of
1.0 for the historical variability experienced in the load material,
i.e. that would guarantee the CQA is always met. However, the
large size of regions where the probabilityo0.95 meant that
rarely would the process fail to meet its objectives if the operating
condition was speciﬁc to the resin lot in use. The large difference
between operating conditions that give p40.95 for each resin are
somewhat surprising given the small difference between the
adsorption isotherm parameters, but are due to the very challen-
ging CQA constraint, combined with the mean and variance of the
inlet composition and concentration.
When the design space must be eligible for all resin lots, then
the probability of achieving the correct product form distribution
in the elution peak should be high for both resin lots. Fig. 8 shows
an overlay of the two resins' probabilistic design spaces. Critically,
there was no operating region where the probability of both the
low and high resin lots remained40.95, i.e. risk of batch fail-
ureo5%. Even at the optimum operating condition where the two
curves intersect (e.g. mass challenge 2 mg/ml, wash length 4 CV),
the probability only reaches 0.84. As a result, the operating
parameter ranges available for manufacturing are small, and at
best, 16% of batches are still predicted to fail product quality
speciﬁcations. In addition, the product form distribution will vary
within the full allowable range (0.25oBo0.45), which is undesir-
able when the objective is to produce a consistent product.
50% (Median)
25% (Quartile)
75% (Quartile)
100% (Maximum)
0% (Minimum)
99%
1%
Outliers
Outliers
MOMENTS 
Standard deviation 3.74
Mean 23
QUARTILES
100 Maximum 42
99.5 34
97.5 31
90 28
75 Quartile 26
50 Median 23
25 Quartile 21
10 19
2.5 16
0.5 14
0 Minimum 10
Fig. 6. CQA data from stochastic simulation at mass challenge 2.5 mg/ml, wash length 5 CV in box plot and probability distribution form with associated moments and
quartiles (low resin).
Fig. 7. Probabilistic design spaces for low binding (right) and high binding (left) resin lots, showing the probability that the resin will achieve the correct product form
distribution in the elution peak over a ranges of possible mass challenges and wash lengths.
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Selecting operating conditions that are eligible for all resin lots
also means that high risk regions are selected, where deviations
from usual inlet stream composition can result in further perfor-
mance issues. For this case study, signiﬁcant increases in process
robustness can be made by adapting the design space based on the
resin lot in use, rather than ﬁxing the design space for all resin lots.
In practice, this would involve varying the length of the wash
length based on the resin lot in use. This adaptive approach
signiﬁcantly increases the size of potential operating regions,
improves ﬂexibility to variations in process inputs, provides a
more consistent product composition, and enables operation
further away from high risk regions. This conclusion, that adaptive
operation can bring signiﬁcant beneﬁts is in agreement with
literature (Gétaz et al., 2013a,2013b), and is a viable mode of
operation under FDA Quality by Design guidance (ICH, 2008a).
The probabilistic design spaces presented are particularly
useful as they provide a quantitative measure of the assurance of
product quality, which either validates the robustness of potential
operating regions, or indicates a need for process improvement.
The stochastic methodology can be easily extended to identify the
level of control required on uncertain parameters/variables to
achieve adequate assurance of quality, by systematically reducing
the variance of uncertain parameters, and measuring the quality
response. Alternatively, when parameter variability is reduced due
to improvements and optimization by process operators as experi-
ence is built over a process lifetime, the method can identify how
operating ranges can be expanded to give greater ﬂexibility to
process operators during manufacturing.
For this case study, the data indicates that if the operating
parameter ranges must be ﬁxed for all resin lots, then process
improvements are needed. Without process improvements, oper-
ating regions that provide assurance of product quality are small
and are not robust. We now consider how decreasing variability in
the product form inlet concentrations via increased control of
upstream unit operations can improve the assurance of quality
when using an operating region ﬁxed for all resins. Better control
was assumed to result in less variability, and therefore a reduced
standard deviation. A detailed description of how this can be
achieved in practice is beyond the scope of this work, but could
include modiﬁcations to upstream processes such as optimizing
the elution stage of preceding afﬁnity chromatographic separa-
tions. In any case, the study is a useful exercise for illustrating how
stochastic simulation and mechanistic models can be used not
only for quantifying risk associated with uncertainty, but for
exploring the relationship between parameter and CQA variance,
a key consideration when validating quality assurance.
Fig. 9 shows box plots indicating predicted variability of the
product CQA (percentage B in the elution peak) as a function of the
variability in the product form inlet concentrations. The mass
challenge was 2 mg/ml and wash length 4 CV, previously identi-
ﬁed as one of the optimal operating points for a ﬁxed design space.
The standard deviations considered include: 0.01, 0.015, 0.02 and
0.024. The probability of meeting the CQA speciﬁcation is indi-
cated next to each box plot (e.g. p¼0.998). As expected, reducing
feed stream uncertainty (i.e. going from 0.024 towards 0.01)
results in a reduction in product CQA variability, which translates
into increases in the probability of meeting quality speciﬁcations
(i.e. for low resin, p¼0.0895 to p¼0.998). When this is completed
for all operating conditions, the size of regions with p40.95 (i.e.
o5% failure) increases. Fig. 10A shows the region where p40.95
Fig. 8. Overlay of high and low resin probabilistic design spaces showing the
operating parameter ranges where product quality is assured with p40.75 for all
resins. No regions were found where product quality was assured with p40.95.
Fig. 9. Box plots showing variability of percentage B in elution peak as a function of
variability in component inlet concentration, with probability of meeting quality
speciﬁcations indicated next to each box plot, for a mass challenge of 2 mg/ml and
wash length 4 CV.
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for both resins at the lowest inlet variability considered
(SD¼0.01). Even with this high level of control over the feed
material, operating regions where p40.95 were signiﬁcantly
smaller than those available if the operating conditions were
adapted according to the resin lot in use under normal inlet
variability (Fig. 7). Fig. 10B shows the design space which assures
product quality for all resins in an ideal (but unrealistic) system
with no inlet variability. The large difference in size between
Fig. 10A (ideal systemwith no inlet variability) and Fig. 10B (lowest
inlet variability considered, SD¼0.01), provides a stark demon-
stration of the importance of considering parameter variances
when designing chromatography processes. If this is not
accounted for, then the result may be unrealistically good expecta-
tions and in turn high failure rates.
5. Conclusion
In this paper, a model based approach was used to identify
robust operating conditions for an industrial hydrophobic interac-
tion chromatography where resin lot variability, combined with a
variable feed stream, was resulting in serious performance issues
during the puriﬁcation of a multi component therapeutic protein
from crude feed material. FDA guidance encourages the applica-
tion of mechanistic models to improve process understanding,
based on fundamental knowledge of the underlying causes which
are linking process parameters to product CQA's. The methodology
demonstrates how useful mechanistic models linked with sto-
chastic simulation can be for this task, for as well as determining
the functional relationship between process parameter values and
the resulting value of the CQA, the use of models can quickly and
efﬁciently determine the relationship between process parameter
and CQA variances, a key aspect of providing assurance of product
quality. This was not possible for the HIC in this case study using a
design of experiment type of approach due to the impractical
amount of resources that would be required.
The model based approach combines mechanistic models and
stochastic simulation, and in this work is used to predict a key
product CQA as function of mass challenge and wash length for
polar extreme resin lots, designated high and low binding resin,
whilst also accounting for uncertainty in feed stream composition
and concentration. With normal process variability, no operating
condition was found where the probability of both the low and
high resin lots meeting product quality speciﬁcations remained
40.95. The risk of batch failure when operating at the most
favorable conditions found in this work was 16%, and selecting
operating conditions that were eligible for both resin lots meant
that operating conditions were not robust. Increasing control on
the inlet concentration and composition was predicted to improve
ﬁxed design space robustness, but we found that using an adaptive
design space, where operating conditions are changed according
to which resin lot is in use, was the favorable option.
Nomenclature
Cm Mobile phase concentration (mg/ml)
Csp Stationary phase concentration (mg/ml)
Cequil Concentration of the equilibration supernatant (mg/ml)
Celution Concentration of the elution supernatant (mg/ml)
CF Compression factor
DA Apparent axial dispersion coefﬁcient (cm
2/s)
F Mobile phase ﬂowrate (ml/s)
i Component identiﬁer
ka Equilibrium constant
L Column length (cm)
Mt Total amount of protein added to the micro well (mg)
NC Number of components
Np Number of theoretical plates
Ploadi Component percentage in load material
Pmi Component percentage in equilibration supernatant
qs Saturation capacity (mg/ml)
q Settled resin concentration (mg/ml)
t0 Retention time (1/s)
t Time (s)
u Interstitial velocity (cm/s)
Velution Volume of the equilibration supernatant (ml)
Vequil Volume of the elution supernatant (ml)
Vresin Settled resin volume in microwell (ml)
VC Column volume (ml)
ϵT Total column porosity
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